Literature DB >> 18545108

Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.

Shahrokh F Shariat1, Quoc-Dien Trinh, Allen F Morey, Key H Stage, Claus G Roehrborn, Luc Valiquette, Pierre I Karakiewicz.   

Abstract

BACKGROUND: To develop and validate a nomogram for predicting the need for renal exploration after renal trauma.
METHODS: From 1995 through 2004, 419 consecutive patients presented to our institution with traumatic renal injury. All were randomly divided into a development (50%, n = 210) and a split sample validation cohort (50%, n = 209). Logistic regression models were used to develop a nomogram for prediction of the need for renal exploration after renal trauma. Internal (200 bootstrap resamples) and 50% split sample validations were performed.
RESULTS: Overall, 89 patients (21.2%) underwent renal exploration, from which 60.7% (54 of 89) underwent nephrectomy and 39.3% (35 of 89) underwent renorrhaphy. Nine percent of patients with grade II injury underwent renal exploration, 16% with grade III injuries, 41% with grade IV injuries, and 100% of grade V injuries. The kidney injury scale, the mechanism of injury, the need for transfusion, blood urea nitrogen level, and serum creatinine represented the most informative predictors and were included in the nomogram. The split sample accuracy of the nomogram for prediction of the need for renal exploration was 96.9%. It significantly (p < 0.001) exceeded the accuracy of each of its components including the American Association for the Surgery of Trauma kidney injury scale (87.7%).
CONCLUSION: The nomogram generates highly accurate and reproducible predictions of the probability for renal exploration according to our decision-making. It could help standardize the management of patients with renal trauma (i.e., inclusion criteria for clinical trials) and serves as a proof-of-principle that predictive tools can be applied to the trauma setting. Its use may improve the management of renal trauma patients at institutions with limited trauma experience.

Entities:  

Mesh:

Year:  2008        PMID: 18545108     DOI: 10.1097/TA.0b013e3181271b77

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

1.  Use of nomograms for predictions of outcome in patients with advanced bladder cancer.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Guilherme Godoy; Seth P Lerner
Journal:  Ther Adv Urol       Date:  2009-04

2.  [Massive bleeding of the urogenital tract].

Authors:  C-A J von Klot; R Fricke; M A Kuczyk; H Tezval
Journal:  Internist (Berl)       Date:  2017-03       Impact factor: 0.743

Review 3.  Critical review of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

4.  External validation of a nomogram predicting risk of bleeding control interventions after high-grade renal trauma: The Multi-institutional Genito-Urinary Trauma Study.

Authors:  Sorena Keihani; Sherry S Wang; Ryan P Joyce; Douglas M Rogers; Joel A Gross; Alexander P Nocera; J Patrick Selph; Elisa Fang; Judith C Hagedorn; Bryan B Voelzke; Michael E Rezaee; Rachel A Moses; Chirag S Arya; Rachel L Sensenig; Katie Glavin; Joshua A Broghammer; Margaret M Higgins; Shubham Gupta; Clara M Castillejo Becerra; Nima Baradaran; Chong Zhang; Angela P Presson; Raminder Nirula; Jeremy B Myers
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.313

5.  Incidence, clinical predictors and outcome of acute renal failure among North Indian trauma patients.

Authors:  Arulselvi Subramanian; Ravindra Mohan Pandey; Chhavi Sawhney; Ashish Dutt Upadhayay; Venencia Albert
Journal:  J Emerg Trauma Shock       Date:  2013-01

Review 6.  Operative and nonoperative management for renal trauma: comparison of outcomes. A systematic review and meta-analysis.

Authors:  Andrea Mingoli; Marco La Torre; Emanuele Migliori; Bruno Cirillo; Martina Zambon; Paolo Sapienza; Gioia Brachini
Journal:  Ther Clin Risk Manag       Date:  2017-08-31       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.